Published online Feb 24, 2021. doi: 10.5306/wjco.v12.i2.50
Peer-review started: January 13, 2021
First decision: January 29, 2021
Revised: February 2, 2021
Accepted: February 5, 2021
Article in press: February 5, 2021
Published online: February 24, 2021
Processing time: 40 Days and 2.1 Hours
Although the whole world has been suffering under the Coronavirus Disease 2019 epidemic, the World Journal of Clinical Oncology (WJCO) was able to productively direct our efforts in the field through 2020. This was only accomplished through the collective efforts and support of our Editorial Board members, peer reviewers, authors, readers and editorial office staff. In 2020, the WJCO published 12 issues encompassing 84 papers, a 115.4% increase over 2019 (39 papers). In December of 2020, we strategized a plan to solicit even more high-quality contributions for WJCO in 2021. So far, we have registered and accepted 188 manuscript titles, including 132 reviews and 56 original articles. In the New Year, we will work with our internal and external colleagues who care about and support the development of WJCO with the express aim of improving the academic rank of WJCO in the field of oncology. Ultimately, our goal is to merit and gain inclusion in the Science Citation Index Expanded, with the first impact factor being awarded as soon as possible.
Core Tip: This editorial introduces the development of World Journal of Clinical Oncology (WJCO) in 2020. We also discuss some of the limitations currently facing the journal and propose solutions that can positively influence the academic rank of WJCO. Finally, we thank all those who have contributed to the development of WJCO and look forward to continuing our collective efforts to strengthen the field of clinical oncology.